Back to News
Market Impact: 0.2
BioAdaptives, Inc. Enters Agreement to Acquire Xycota Biosciences LLC
Source: Nasdaq
M&A & RestructuringHealthcare & Biotech
On October 29, 2026, BioAdaptives, Inc. entered into a definitive agreement to acquire 100% of Xycota Biosciences LLC, a preclinical biotechnology company developing central-nervous-system products. The available article text provides no purchase price, financing details, or expected closing timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- China Blocks SoftBank Acquisition of ABB Robot Unit, FT Says
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Host Hotels & Resorts CEO on 3Q Quarterly Results
- NextDC shares surge 43% as Goodman, Digital Realty buy stake
- Australia’s 188-year-old retailer David Jones enters administration, faces sale
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)
- How to Extract KPIs From Earnings Transcripts With AI